UPDATE: Cowen Starts Foamix Pharmaceuticals (FOMX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Barclays Starts Foamix Pharmaceuticals (FOMX) at Overweight
October 13, 2014 6:43 AM EDTBarclays initiated coverage on Foamix Pharmaceuticals (NASDAQ: FOMX) with an Overweight rating and a price target of $11.00.
For an analyst ratings summary and ratings history on Foamix Pharmaceuticals click here. For more ratings news on Foamix Pharmaceuticals click here.
Shares of Foamix Pharmaceuticals closed at $5.08 yesterday.
... More